Consumers Challenge DMAA Safety After DOD Bans Products
This article was originally published in The Tan Sheet
Executive Summary
Complaints against GNC Holdings Inc., manufacturer Cellucor Sports Nutrition and Woodbolt Distribution and against USPLabs rely on DOD’s decision to ban sales of the product at military exchanges and moves by Canadian regulators to support their arguments.
You may also be interested in...
DMAA Targeted In N.Y. Ban Effort, USP Labs Settles
A New York lawmaker moves to ban DMAA sales in the state, and USP Labs sets aside $2 million to settle class action suit over the product. FDA continues to work with firms that received related warning letters.
DMAA Targeted In N.Y. Ban Effort, USP Labs Settles
A New York lawmaker moves to ban DMAA sales in the state, and USP Labs sets aside $2 million to settle class action suit over the product. FDA continues to work with firms that received related warning letters.
Senate Appropriators Call For Botanical Identity Testing Guidance
A Senate FDA appropriation report says the guidance would enhance the agency’s ability to inspect and assess industry practices for manufacturing botanical dietary supplements. A National Center for Natural Products Research official says most botanical ingredients lack standard identity tests.